New genetic markers have been developed by researchers in the UK and Spain to predict how well a person’s cancer will respond to certain types of chemotherapy. These markers, called CIN signatures, measure chromosomal instability in a tumor and can tell doctors if a patient is likely to be resistant to specific drugs. The biomarkers were […]
Breakthrough CIN Biomarkers: Predicting Chemotherapy Resistance Read More »
Researchers have achieved a major breakthrough in liver cancer treatment by combining traditional radiation therapy with microbubble ultrasound contrast agents. The studies found patients with aggressive intrahepatic cholangiocarcinoma (ICC) and liver metastasis showed a greater than 50% improvement in tumor response rates, while patients with hepatocellular carcinoma (HCC) experienced significant improvements in both tumor response
Microbubble Ultrasound Contrast Enhances Liver Cancer Treatment Response Read More »
Ultrasound-guided biopsy is an effective method for obtaining tissue from peripheral lung lesions, pleura, or metastatic nodes, allowing accurate lung cancer diagnosis. Both radiologists and pulmonologists can perform the procedure, which has a high diagnostic yield. Two main techniques are used: fine-needle aspiration and core biopsy. A study by researchers at Alexandria University found overall
Study Confirms High Effectiveness of Ultrasound-Guided Lung Cancer Diagnosis Read More »
AI and liquid biopsy technologies are transforming cancer detection, diagnosis, and treatment planning. Advanced AI algorithms are now capable of analyzing biopsy slides to identify microscopic tumor features that may be overlooked by human pathologists. For example, the DeepHRD tool evaluates standard slides to detect specific genetic deficiencies, guiding personalized treatment decisions. AI is also
AI and Liquid Biopsy Revolutionize Early Lymphoma Detection Read More »
RRestricted blood flow, or ischemia, can accelerate bone marrow aging and weaken the immune system’s ability to fight cancer. In a recent study on mice with breast tumors, restricting blood flow to the legs caused tumors to grow twice as fast. This occurs because ischemia disrupts bone marrow function, shifting the production of immune cells
Restricted Blood Flow Accelerates Cancer Growth by Aging Immune System, Study Finds Read More »
Researchers have developed a breakthrough blood test for mesothelioma, a rare cancer of the organ linings often caused by asbestos exposure. Because mesothelioma spreads diffusely rather than forming solid tumors, traditional imaging struggles to detect its presence or track treatment effectiveness. The new approach, developed by teams at Johns Hopkins University and Georgetown University, detects
Molecular Blood Analysis Surpasses Imaging in Early Mesothelioma Detection Read More »
Leukemia treatment is advancing rapidly with targeted therapies and immunotherapies that offer more precise and less toxic alternatives to traditional chemotherapy. A breakthrough in 2025 is the development of menin inhibitors, which block the interaction between menin and KMT2A proteins critical for leukemia cell survival. Revumenib, approved by the FDA, has shown high remission rates
Next-generation cancer vaccines are revolutionizing oncology by combining personalized design, mRNA technology, and artificial intelligence (AI). Unlike traditional vaccines that target a single common antigen, these vaccines are tailored to each patient’s tumor, addressing the challenge of tumor heterogeneity and improving treatment specificity. The process begins with tumor sequencing to identify unique mutations called neoantigens.
Next-Generation Cancer Vaccines: Personalized, mRNA, and AI-Driven Innovations Read More »
Recent oncology developments have introduced several innovative therapies across solid and blood cancers, offering new treatment options for patients with previously limited choices. Inlexzo, an FDA-approved gemcitabine intravesical system, provides extended local delivery for adults with BCG-unresponsive non-muscle invasive bladder cancer, reducing the need for repeated procedures. Ifinatamab deruxtecan (I-DXd), a B7-H3 directed antibody-drug conjugate,
Recent Advances in Cancer Treatment: New Approvals and Promising Trials Read More »
Colorectal cancer (CRC) treatment is rapidly evolving from traditional chemotherapy to personalized, molecularly guided therapies. Precision medicine allows clinicians to analyze tumor genetics and target mutations in genes like RAS, BRAF, and HER2, providing new options for previously hard-to-treat subtypes. Immunotherapy has been particularly impactful for the 5–15% of CRC tumors that are microsatellite instability-high